M.Pharm Ph.D. D.Sc. Lisbeth ILLUM
Chief Executive Officer, Critical Pharmaceuticals Ltd., Nottingham
Lisbeth Illum was the founder and for 12 years the Managing Director of DanBioSyst UK Ltd., a company that specialises in Drug Delivery Systems. She was the Managing Director of Phaeton Research Ltd. and is now Director of IDentity, a consultancy company and the CEO of Critical Pharmaceuticals Ltd, a drug delivery company. She is also associated with Nottingham University, Department of Pharmaceutical Sciences and Department of Chemistry, as a Special Professor. She was awarded her M. Pharm, Ph. D and D.Sc. from the Royal Danish School of Pharmacy in 1972, 1978 and 1988, respectively. Her research expertise covers the area of novel drug delivery systems for difficult drugs such as polar small molecular weight compounds and peptides and proteins. She has studied the novel approaches to the delivery of such drugs using transmucosal routes such as the nasal, the oral and the vaginal. She has published more than 325 scientific papers and has co-edited four books including "Peptide Drug Delivery Systems" published by Plenum Press, 1986. She has filed nearly fifty patents on novel drug delivery systems. She has been awarded the title of "Docent" in the Royal Danish School of Pharmacy and has been the recipient of several scientific awards. She has been elected a Fellow of the AAPS and of the CRS. She has lectured throughout the world at conferences and workshops and is on the Editorial Boards of seven scientific journals. She was in 2008/2009 the President of the CRS.